Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity

重编程和致癌转化的比较路线图表明,Bcl11b 和 Atoh8 是细胞可塑性的广泛调控因子。

阅读:8
作者:A Huyghe # ,G Furlan # ,J Schroeder ,E Cascales ,A Trajkova ,M Ruel ,F Stüder ,M Larcombe ,Y Bo Yang Sun ,F Mugnier ,L De Matteo ,A Baygin ,J Wang ,Y Yu ,N Rama ,B Gibert ,J Kielbassa ,L Tonon ,P Wajda ,N Gadot ,M Brevet ,M Siouda ,P Mulligan ,R Dante ,P Liu ,H Gronemeyer ,M Mendoza-Parra ,J M Polo ,F Lavial

Abstract

Coordinated changes of cellular plasticity and identity are critical for pluripotent reprogramming and oncogenic transformation. However, the sequences of events that orchestrate these intermingled modifications have never been comparatively dissected. Here, we deconvolute the cellular trajectories of reprogramming (via Oct4/Sox2/Klf4/c-Myc) and transformation (via Ras/c-Myc) at the single-cell resolution and reveal how the two processes intersect before they bifurcate. This approach led us to identify the transcription factor Bcl11b as a broad-range regulator of cell fate changes, as well as a pertinent marker to capture early cellular intermediates that emerge simultaneously during reprogramming and transformation. Multiomics characterization of these intermediates unveiled a c-Myc/Atoh8/Sfrp1 regulatory axis that constrains reprogramming, transformation and transdifferentiation. Mechanistically, we found that Atoh8 restrains cellular plasticity, independent of cellular identity, by binding a specific enhancer network. This study provides insights into the partitioned control of cellular plasticity and identity for both regenerative and cancer biology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。